Since November 2025, Elanco has been in a holding pattern, floating around $21.39. The stock also fell short of the S&P 500’s ...
The settlement, which involves several retailers, comes nearly two years after a complaint was filed in the U.S. District Court for the Southern District of Indiana accusing Elanco of monopolizing the ...
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the phased launch of Befrena™ (tirnovetmab), a new anti-IL-31 ...
Tirnovetmab (Befrena; Elanco) injection received USDA approval in late 2025. A new anti-IL-31 monoclonal antibody (mAb) ...
Elanco has promoted Shiv O'Neill to general counsel. O'Neill replaces Marcela A. Kirberger, who left the company last November. Shareholder activist Ancora is calling for a shake-up of the board and ...
View Elanco Animal Health, Inc. ELAN stock quote prices, financial information, real-time forecasts, and company news from CNN.
Hosted on MSN
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations
Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came ...
The stock price of Elanco (NYSE: ELAN), an animal health products company, saw a 20% fall on Thursday, June 27, after the company announced a delay in expected approval of two drugs. In comparison, ...
Shares of Elanco Animal Health Incorporated ELAN are trading higher on Wednesday, following a recent announcement regarding ...
Demand for drugs to combat ticks and other pests was a major factor boosting Elanco Animal Health Inc.'s first quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results